Clinical phase I and pharmacokinetic trial of vinorelbine administered as single intravenous bolus every 21 days in cancer patients
Investigational New Drugs1996Vol. 14(4), pp. 371–378
Citations Over Time
T. Schilling, Heiner Fiebig, Sándor Kerpel‐Fronius, B. R. Winterhalter, Philipp Variol, Patricia Tresca, Bernhard Heinrich, Axel‐R. Hanauske
Related Papers
- → Vinorelbine (Navelbine®) in the treatment of non-small-cell lung cancer: Studies with single-agent therapy and in combination with cisplatin(1999)17 cited
- [Vinorelbine in the treatment of non-small-cell lung cancer and breast cancer].(2000)
- → Phase II study of alternating doses of vinorelbine in combination with cisplatin for non-small cell lung cancer (NSCLC): a disappointing experience(1996)6 cited
- → Vinorelbine as a monotherapy in metastatic breast cancer treatment(2017)
- Shenfu injection plus vinorelbine for elderly patients with non-small cell lung cancer in promoting the quality of life： a randomized controlled clinical trial(2010)